Skip to main content

Signed · Poland · Pharma and biotech

Abacus Medicine Group agrees to acquire Delfarma.

Copenhagen-based parallel distributor Abacus Medicine Group agreed on 14 September 2026 to buy Delfarma, a Polish parallel importer of medicines with its own repackaging production. The deal marks the group's entry into Poland and needs Polish competition clearance, expected within six to eight weeks. It was signed on 14 September 2026. It had not completed by 28 October 2026.

SigningDay 100

Signing 14 September 2026

Buyer
Abacus Medicine Group ·Copenhagen, Denmark
Target
Delfarma ·Lodz, Poland
Type
Acquisition
Announced
14 September 2026
Signed
14 September 2026
Value
Not disclosed
People
Not stated in the release
Last checked
28 October 2026

The people side in Poland

Get the briefing

Deals into Europe lists public facts with their sources, checked every working day by Octagon Professionals International. Corrections go to info@octagon.nl and are made within one working day. How we track deals.

Enabling organisations to operate across borders with clarity, compliance, and trust.

All deals into Europe